Cargando…
Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation?
Defects in glycinergic inhibition result in a complex neuromotor disorder in humans known as hyperekplexia (OMIM 149400) with similar phenotypes in rodents characterized by an exaggerated startle reflex and hypertonia. Analogous to genetic defects in humans single point mutations, microdeletions, or...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484359/ https://www.ncbi.nlm.nih.gov/pubmed/23118727 http://dx.doi.org/10.3389/fnmol.2012.00098 |
_version_ | 1782248135640219648 |
---|---|
author | Schaefer, Natascha Vogel, Nicolas Villmann, Carmen |
author_facet | Schaefer, Natascha Vogel, Nicolas Villmann, Carmen |
author_sort | Schaefer, Natascha |
collection | PubMed |
description | Defects in glycinergic inhibition result in a complex neuromotor disorder in humans known as hyperekplexia (OMIM 149400) with similar phenotypes in rodents characterized by an exaggerated startle reflex and hypertonia. Analogous to genetic defects in humans single point mutations, microdeletions, or insertions in the Glra1 gene but also in the Glrb gene underlie the pathology in mice. The mutations either localized in the α (spasmodic, oscillator, cincinnati, Nmf11) or the β (spastic) subunit of the glycine receptor (GlyR) are much less tolerated in mice than in humans, leaving the question for the existence of different regulatory elements of the pathomechanisms in humans and rodents. In addition to the spontaneous mutations, new insights into understanding of the regulatory pathways in hyperekplexia or glycine encephalopathy arose from the constantly increasing number of knock-out as well as knock-in mutants of GlyRs. Over the last five years, various efforts using in vivo whole cell recordings provided a detailed analysis of the kinetic parameters underlying glycinergic dysfunction. Presynaptic compensation as well as postsynaptic compensatory mechanisms in these mice by other GlyR subunits or GABA(A) receptors, and the role of extra-synaptic GlyRs is still a matter of debate. A recent study on the mouse mutant oscillator displayed a novel aspect for compensation of functionality by complementation of receptor domains that fold independently. This review focuses on defects in glycinergic neurotransmission in mice discussed with the background of human hyperekplexia en route to strategies of compensation. |
format | Online Article Text |
id | pubmed-3484359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-34843592012-11-01 Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? Schaefer, Natascha Vogel, Nicolas Villmann, Carmen Front Mol Neurosci Neuroscience Defects in glycinergic inhibition result in a complex neuromotor disorder in humans known as hyperekplexia (OMIM 149400) with similar phenotypes in rodents characterized by an exaggerated startle reflex and hypertonia. Analogous to genetic defects in humans single point mutations, microdeletions, or insertions in the Glra1 gene but also in the Glrb gene underlie the pathology in mice. The mutations either localized in the α (spasmodic, oscillator, cincinnati, Nmf11) or the β (spastic) subunit of the glycine receptor (GlyR) are much less tolerated in mice than in humans, leaving the question for the existence of different regulatory elements of the pathomechanisms in humans and rodents. In addition to the spontaneous mutations, new insights into understanding of the regulatory pathways in hyperekplexia or glycine encephalopathy arose from the constantly increasing number of knock-out as well as knock-in mutants of GlyRs. Over the last five years, various efforts using in vivo whole cell recordings provided a detailed analysis of the kinetic parameters underlying glycinergic dysfunction. Presynaptic compensation as well as postsynaptic compensatory mechanisms in these mice by other GlyR subunits or GABA(A) receptors, and the role of extra-synaptic GlyRs is still a matter of debate. A recent study on the mouse mutant oscillator displayed a novel aspect for compensation of functionality by complementation of receptor domains that fold independently. This review focuses on defects in glycinergic neurotransmission in mice discussed with the background of human hyperekplexia en route to strategies of compensation. Frontiers Media S.A. 2012-10-31 /pmc/articles/PMC3484359/ /pubmed/23118727 http://dx.doi.org/10.3389/fnmol.2012.00098 Text en Copyright © 2012 Schaefer, Vogel and Villmann. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
spellingShingle | Neuroscience Schaefer, Natascha Vogel, Nicolas Villmann, Carmen Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? |
title | Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? |
title_full | Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? |
title_fullStr | Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? |
title_full_unstemmed | Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? |
title_short | Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? |
title_sort | glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484359/ https://www.ncbi.nlm.nih.gov/pubmed/23118727 http://dx.doi.org/10.3389/fnmol.2012.00098 |
work_keys_str_mv | AT schaefernatascha glycinereceptormutantsofthemousewhatarepossibleroutesofinhibitorycompensation AT vogelnicolas glycinereceptormutantsofthemousewhatarepossibleroutesofinhibitorycompensation AT villmanncarmen glycinereceptormutantsofthemousewhatarepossibleroutesofinhibitorycompensation |